bq 610 has been researched along with Insulin Resistance in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, SF; Chien, Y; Ho, LT; Juan, CC; Lin, YJ; Shen, YW | 1 |
Busija, DW; Miller, AW; Puskar, M; Tulbert, C | 1 |
2 other study(ies) available for bq 610 and Insulin Resistance
Article | Year |
---|---|
Insulin infusion induces endothelin-1-dependent hypertension in rats.
Topics: Animals; Blood Glucose; Disease Models, Animal; Drug Administration Schedule; Endothelin A Receptor Antagonists; Endothelin-1; Hyperinsulinism; Hypertension; Infusions, Intravenous; Insulin; Insulin Resistance; Male; Oligopeptides; Rats; Rats, Sprague-Dawley | 2004 |
Enhanced endothelin activity prevents vasodilation to insulin in insulin resistance.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelins; Glyburide; In Vitro Techniques; Indomethacin; Insulin; Insulin Resistance; Male; Mesenteric Artery, Superior; Oligopeptides; Potassium Chloride; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Vasodilation | 2002 |